Persistence of Anti-SARS-CoV-2 Antibodies Six Months after Infection in an Outbreak with Five Hundred COVID-19 Cases in Borriana (Spain): A Prospective Cohort Study

نویسندگان

چکیده

In March 2020, several mass gathering events were related to the Falles festival in Borriana (Spain), resulting a 536 laboratory-confirmed COVID-19 cases outbreak among participants. This article estimates anti-SARS-CoV-2 antibodies persistence six months after and factors associated with antibody response. A prospective population-based cohort study was carried out by Public Health Centre of Castellon Emergency Clinical Analysis Microbiology Services Hospital de la Plana Vila-real. October seroepidemiologic used estimate against nucleocapsid protein (N) an electrochemiluminescence immunoassay (ECLIA) implemented. We enrolled 484 (90.2%) members initial detected persistent 479 (99%) without reinfection episodes. Five participants had negative test. Factors result lower body index (BMI), less contact other cases. Among 469 two ECLIA tests, 96 (20.5%) increase 373 (79.5%) decline. Increased older age, higher BMI, more severe illness, low current smokers. Our results show that infection, high proportion maintain detectable antibodies.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A review of coronaviruses focusing on SARS-CoV-2 (2019-nCoV) the cause of COVID-19

Coronaviruses, enveloped positive single-stranded RNA viruses, have become significant pathogens for humans and other vertebrates since the outbreak of SARS (severe acute respiratory syndrome) in 2002 in China. These viruses could infect the respiratory tract of humans and other animals. The outbreaks of SARS and MERS (Middle East respiratory syndrome), which Bats are thought to be the origin o...

متن کامل

Angiotensin-Converting Enzymes, the Key Components in the Pathogenesis of COVID-19 Infection and their Role in the Interaction of SARS-Cov-2 with Human Host Cells

Introduction: Over the past 20 years, seven coronaviruses have caused more or less severe respiratory diseases in humans. Among these, the most important ones are SARS-CoV and the coronavirus, a similar virus that has created a pandemic called Covid-19 since 2019, belonging to the b-category of beta-coronaviruses called Sarbecovirus. This virus is due to a kind of spike-like structure to the A...

متن کامل

SARS-CoV-2 infection: its psychiatric manifestations

Background:  The clinical presentation of SARS-CoV-2 infection was initially dominated by respiratory symptoms. However the clinical spectrum is wide and neuropsychiatric syndromes are also a source of medical concern. Our aims are to present an atypical clinical presentation of SARS-CoV-2 infection characterized by auditory hallucinations and unusual behavior and to emphasize the diversity of ...

متن کامل

COVID-19: a hypothesis to prevent SARS-CoV-2 from entering respiratory cells

Coronaviruses (CoVs) are a group of viruses that induce infection in the respiratory and other systems in the human body. There are two coronaviruses that transmitted from animals to humans including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) (1). The novel coronavirus that appeared at first in Wuhan, China, in December 2019 was named as severe acut...

متن کامل

SARS-CoV-2 and COVID-19, evidence from a literature review: review article

  SARS-CoV-2 emerging from Wuhan, China is a member of the Coronaviridae family, which has so far infected and killed many people. The SARS-CoV-2 pandemic affected various aspects of life in Iran and Worldwide, and governments have imposed quarantines and travel bans on an unprecedented scale. The virus causes COVID-19, which can spread through close contact with the infected person, contaminat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: COVID

سال: 2021

ISSN: ['2673-8112']

DOI: https://doi.org/10.3390/covid1010006